Briviact (UCB, Inc.)


Welcome to the PulseAid listing for the Briviact drug offered from UCB, Inc.. This Epoxide Hydrolase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: UCB, Inc.
NON-PROPRIETARY NAME: brivaracetam
SUBSTANCE NAME: BRIVARACETAM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Epoxide Hydrolase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-05-12
END MARKETING DATE: 0000-00-00


Briviact HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBriviact from UCB, Inc.
LABELER NAME: UCB, Inc.
DEA SCHEDULE: CV
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2016-05-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50474-370_7d59b2b8-0e38-4a6a-8e63-488ca47a0288
PRODUCT NDC: 50474-370
APPLICATION NUMBER: NDA205836

Other BRIVARACETAM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
UCB, Inc.Briviact